Anastrozole

Common brands: Arimidex, Ibrance, Vitamin D, Aspirin 325, Aspirin 81

Top reporter: Ani Pharmaceuticals, Inc.

Aromatase Inhibitor [EPC]Kinase Inhibitor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Provitamin D2 Compound [EPC]Proton Pump Inhibitor [EPC]
35,755
Total Reports
12,218
Serious Reports
2,401
Death Reports
30
Reported Reactions
Death Report Ratio: High (6.72%)

Patient Demographics

Male
1,632
Female
31,673

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Anastrozole.

# Reaction Reports % of Total
1 FATIGUE 3,340
7.4%
2 ARTHRALGIA 3,188
7.0%
3 NAUSEA 2,709
6.0%
4 ALOPECIA 2,557
5.6%
5 DIARRHOEA 2,329
5.1%
6 PAIN 1,802
4.0%
7 HEADACHE 1,775
3.9%
8 ASTHENIA 1,592
3.5%
9 DYSPNOEA 1,563
3.5%
10 DIZZINESS 1,499
3.3%
11 HOT FLUSH 1,413
3.1%
12 PAIN IN EXTREMITY 1,390
3.1%
13 MALIGNANT NEOPLASM PROGRESSION 1,355
3.0%
14 VOMITING 1,301
2.9%
15 MALAISE 1,298
2.9%
16 INSOMNIA 1,282
2.8%
17 OFF LABEL USE 1,213
2.7%
18 DRUG INEFFECTIVE 1,205
2.7%
19 COUGH 1,154
2.5%
20 FALL 1,151
2.5%
21 DECREASED APPETITE 1,135
2.5%
22 MYALGIA 1,061
2.3%
23 METASTASES TO BONE 1,054
2.3%
24 PRURITUS 1,040
2.3%
25 BREAST CANCER 1,038
2.3%
26 BONE PAIN 1,022
2.3%
27 WHITE BLOOD CELL COUNT DECREASED 986
2.2%
28 BACK PAIN 963
2.1%
29 ANXIETY 942
2.1%
30 DEATH 939
2.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.